<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <ref-type name="Journal Article">17</ref-type>
  <contributors>
    <authors>
      <author>Lázaro, Diana F</author>
      <author>Amen, Triana</author>
      <author>Gerhardt, Ellen</author>
      <author>Song, Chengyuan</author>
      <author>Burns, Ryan</author>
      <author>Kruse, Niels</author>
      <author>Santos, Patrícia I</author>
      <author>Milovanovic, Dragomir</author>
      <author>Höglinger, Günter</author>
      <author>Mollenhauer, Brit</author>
      <author>Luk, Kelvin C</author>
      <author>Lee, Virginia My-</author>
      <author>Outeiro, Tiago</author>
    </authors>
    <subsidiary-authors>
      <author>AG Fischer</author>
      <author>AG Milovanovic (Berlin)</author>
      <author>Clinical Research (Munich)</author>
    </subsidiary-authors>
  </contributors>
  <titles>
    <title>Synphilin-1 modulates alpha-synuclein assembly, release and uptake.</title>
    <secondary-title>npj Parkinson's Disease</secondary-title>
  </titles>
  <periodical>
    <full-title>npj Parkinson's Disease</full-title>
  </periodical>
  <publisher>Springer Nature</publisher>
  <pub-location>[London]</pub-location>
  <isbn>2373-8057</isbn>
  <electronic-resource-num>10.1038/s41531-025-01144-3</electronic-resource-num>
  <language>English</language>
  <pages>326</pages>
  <number>1</number>
  <volume>11</volume>
  <abstract>Alpha-synuclein (aSyn) is an intrinsically disordered protein involved in phase separation and several age-associated neurodegenerative disorders, including Parkinson's disease. However, its function and pathological role remain elusive. Here, we modeled different aSyn assemblies in living cells by exploiting its interaction with synphilin-1 (Sph1). We developed a model that reports on gel- and solid-like inclusions through coexpression of aSyn and Sph1. Distinct morphological differences emerged between VN-aSyn + aSyn-VC and VN-Sph1 + aSyn-VC assemblies, showing unique antibody recognition, proteinase K resistance, and protein mobilities. The VN-Sph1 + aSyn-VC interaction could be manipulated to alter inclusion size and number. These inclusions also contained lysosomes and AP-1 vesicles, aligning with observations in human brain tissue. Our study offers new insight into aSyn aggregation and release, highlighting the importance of Sph1 and other aSyn-interacting proteins in synucleinopathies, which involve diverse copathologies only now beginning to be understood.</abstract>
  <notes/>
  <label>PUB:(DE-HGF)16, ; 0, ; </label>
  <keywords/>
  <accession-num/>
  <work-type>Journal Article</work-type>
  <dates>
    <pub-dates>
      <year>2025</year>
    </pub-dates>
  </dates>
  <accession-num>DZNE-2025-01297</accession-num>
  <year>2025</year>
  <custom2>pmc:PMC12635182</custom2>
  <custom6>pmid:41266386</custom6>
  <urls>
    <related-urls>
      <url>https://pub.dzne.de/record/282474</url>
      <url>https://doi.org/10.1038/s41531-025-01144-3</url>
    </related-urls>
  </urls>
</record>

</records>
</xml>